Results 101 to 110 of about 8,261 (192)
CoronaVac: more data for regulators and policy makers [PDF]
The Lancet, 2021 Ramasamy, Maheshi N, Jessop, Lucy J
openaire +2 more sources
Journal of Medical Virology, Volume 97, Issue 6, June 2025.ABSTRACT This nationwide population‐based ecological study investigated changes in the incidence of Bell's palsy (BP) in South Korea during the COVID‐19 pandemic. Patients diagnosed with BP between January 2017 and December 2022 were analyzed. Considering the unique progression of the COVID‐19 pandemic and corresponding public health responses in South
Seungyeon Lee +3 more
wiley +1 more source
Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities
, 2023 Although humoral responses elicited by infection or vaccine lost the ability to prevent transmission against Omicron, vaccine-induced antibodies may still contribute to disease attenuation through Fc-mediated effector functions.
Lili Wang (104605) +10 more
core +1 more source
A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac [PDF]
American Journal of Respiratory and Critical Care Medicine, 2022 Chris Ka Pun Mok +9 more
openaire +2 more sources
Immunogenicity of the CoronaVac vaccine in children: a real-world study
Frontiers in ImmunologyBackgroundDespite its proven effectiveness and safety, there are limited real-world data on CoronaVac’s immunogenicity in children, especially in lower-income countries, particularly for SARS-CoV-2 variants. We present a real-world study evaluating CoronaVac’s immunogenicity in Colombian children stratified by previous exposure to this virus.Methods89 ...
Wbeimar Aguilar-Jimenez +14 more
openaire +3 more sources
Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application
Journal of Medical Virology, Volume 97, Issue 6, June 2025.ABSTRACT Adeno‐associated virus (AAV) is a non‐enveloped DNA virus infecting a wide variety of species, tissues, and cell types, which is recognized as a safe and effective method for delivering therapeutic transgenes. AAV vector is the most popular viral gene delivery system in clinical delivery systems with unique and multiple advantages, such as ...
Ling Yin +6 more
wiley +1 more source
CoronaVac or BNT162b2 Vaccine as a Third Dose
American Journal of Respiratory and Critical Care Medicine, 2022 Rujittika Mungmunpuntipantip +1 more
openaire +2 more sources
Intradermal ChAdOx1 Vaccine Following Two CoronaVac Shots: A Case Report
, 2021 Inactivated SARS-CoV-2 vaccines are used in many countries with uncertain immunogenicity. Intradermal ChAdOx1 has been proposed as a resource-efficient heterologous third booster shot.
Ekachai Singhatiraj +7 more
core +1 more source
Adverse events associated with CoronaVac in a university hospital
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2022 Objective: The present study aimed to describe suspected adverse events (AEs) reported in employees of a teaching hospital in the state of Sergipe after vaccination with CoronaVac. Methods: This is a cross-sectional study based on reports of post-vaccination adverse event notification forms (APVs) from the Hospital Surveillance application (Vigihosp ...
Lana N. SILVA-SANTOS +6 more
openaire +1 more source
, 2023 Introduction: Data regarding inactivated vaccines for SARS-CoV-2 in patients undergoing maintenance hemodialysis (MHD) are limited. We aimed to investigate humoral responses induced by CoronaVac compared to BNT162b2 in this population.
TUĞCU, MURAT +1 more
core +1 more source